Athersys Reports That Healios Has Completed Enrollment in the ONE-BRIDGE Study of MultiStem® for Acute Respiratory Distress Syndrome in Japan
Off-the-shelf stem cell therapy has potential to enhance recovery for ARDS patients CLEVELAND--(BUSINESS WIRE)--$ATHX #ARDS--Athersys, Inc. (Nasdaq: ATHX) announced today...






